[Endothelium derived relaxing factor and its effect on vascular disease].
The finding of endothelium derived relaxing factor (EDRF) and the illumination of its chemical identity, bio-synthesis and physiological functions promoted greatly the research on vascular disease. The EDRF was verified as NO or R-O-NO by many experimental results, and several pathological processes such as hypertension, atherosclerosis and heart failure were considered to be associated with abnormalities of endothellium-dependent vascular relaxation and decrease of basal EDRF and/or storage EDRF. As the provider of EDRF, Nitryl vascular relaxation substance could remedy EDRF and might play an important role in clinical therapy and prevention of human vascular disease.